In his report, Senator Bill Cassidy suggested a slate of changes to the FDA to support broader drug access and to red...
Senator Bill Cassidy released a report proposing multiple FDA reforms aimed at expanding drug access and reducing regulatory burdens on manufacturers.
Why it mattersFDA reform proposals could shorten approval timelines, prompting biotech investors to reprioritize pipeline funding.